New research published in the American Journal of Health-System Pharmacy suggests a possible link between the GLP-1 drug ...

The Wall Street Journal published a series of investigative articles last year that reported on questionable practices by UnitedHealth and other insurers that boosted their payments in the Medicare ...

During a hearing, senators asked HHS Secretary Robert F. Kennedy Jr. to explain the rationale for the reorganization changes the agency has made since he was confirmed.

In 2023, the Blue Shield of California announced that it was dropping CVS Caremark as its pharmacy benefit manager (PBM) and ...

Financial toxicity can affect patient outcomes and quality of life. For example, a patient may forgo treatment or medications ...

A Republican-led bill aiming to tighten Medicaid eligibility and impose work requirements sparked heated protests and clashes ...

There are several ways to address HIV in homeless populations, with the most promising being the low barrier care model, ...

Researchers have found that Sotyktu, which inhibits the protein TYK2, protects insulin-producing beta cells and, at the same ...

In a Q&A with Leanne Berge, J.D., CEO of Community Health Plan of Washington, Berge explains what the newly proposed Medicaid ...

Industry leaders and policy experts have said President Trump’s executive order on Most Favored Drug Pricing is flawed and ...

Witty was the top executive of the country's largest healthcare company during some of its darkest chapters, including the ...

The House Energy and Commerce Committee has scheduled a public markup hearing for the Republican bill for tomorrow at 2 p.m.